realclearhealth.com / Page 2

The Trump Administration's efforts to lower prescription drug prices has resulted in progress on a new approach to getting brand name drug manufacturers to announce price reductions in con ...

It's time for USTR to get serious about Europe's unfair pharmaceutical trade practices. Indications are that the innovative biopharmaceutical industry is finally ready to stand up for itse ...

Supporters of Obamacare promised that the legislation would cut family premiums by $2,500. Instead, its mix of mandates and pricing restrictions sharply increased individual market premiu ...

As lawmakers in Washington debate the future of enhanced premium tax credits, they must not overlook their critical support for the backbone of America's Main Street. These tax credits have alwa ...

Picture a clinic where test results are summarized in seconds, rare diseases are flagged before symptoms spiral, and clinical trials enroll the right patients in days--not months. That future i ...

In the past decade, independent drugstores have been vanishing, especially in low-income, minority, and rural communities, in part due to pharmacy benefit managers (PBMs) having rigged the system in f ...

America's rural health care system is in crisis and has been for a long time. Hospitals are closing, doctors are leaving, and patients are driving hours just to get basic care. The $50 billion R ...

If you've turned on a television, scrolled through social media, or streamed a podcast lately, chances are you've encountered a familiar pitch: a solemn voice intones that a drug you&rsqu ...

Debunking KFF's Premium Increase Canard Chris Jacobs's Wall Street Journal op-ed exposes a false claim of Obamacare plan premiums doubling if Biden's COVID credits exp ...

When evaluating an advocacy group's views on public policy, it helps to consider the source. In the case of AARP, that means scrutinizing the sizable conflicts of interest that compromise the or ...